Myelodysplastic Syndrome (MDS) is formerly known as preleukemia. It is a collection of heterogeneous hematopoietic disorder. The disorders that belong to this group are characterized by either a hypo cellular or hyper cellular marrow with its maturation and morphology impaired. Simply put, they are conditions that have resulted due to ineffective production of blood cells. #myelodysplasticsyndrome #medicalook
New advancements are being made in the treatment of cancer with chemotherapy, but unfortunately, most patients will still experience uncomfortable or painful side effects from treatment. One benefit of Chemotherapy Resistance/Sensitivity Testing like ChemoFx, is that it can help find effective chemotherapy treatments for the individual patient, preventing the toxicity a patient experiences due to ineffective drugs, incompatible with their unique biology.
Transitional cell carcinoma of the renal pelvis is uncommon compared to renal cell carcinoma, and can be challenging to identify on routine imaging when small. Transitional cell carcinomas account for 85 % of all uroepithelial tumours of the renal pelvis (the remaining 5 % being made up of squamous cell carcinoma (the majority) and adenocarcinoma (rare). http://radiopaedia.org/articles/transitional-cell-carcinoma-of-the-renal-pelvis